Medical News

RSS

Nanotechnology holds promise for developing surgical measures

A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may provide powerful new tools that could have a marked impact on the therapeutic and diagnostic measures available to surgeons.

2 Mar 2011

Nations meet to negotiate international food aid terms

A group of nations are meeting in London this week to negotiate the Food Aid Convention (FAC), an "international agreement that governs food-aid commitments to hungry countries," the Globe and Mail reports. Argentina, Australia, Canada, the European Union and its member states, Japan, Norway, Switzerland and the U.S. currently are included in the convention, which was last updated in 1999.

2 Mar 2011

New research finds link between genomic variants in neurological processes and autism

New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.

2 Mar 2011

Researchers discover three genes that contribute to abnormal growth

By working with Canadians of French ancestry who suffer a rare genetic disease, researchers have discovered how three genes contribute to abnormal growth, making a breakthrough that will improve our understanding of many disorders such as foetal and childhood growth retardation, abnormal development of body parts and cancer.

2 Mar 2011

Market demands shape health sector growth

The Wall Street Journal reports on how a string of recent acquisitions are being spurred by an increased demand for outpatient facilities and senior care. However, The Washington Post reports that some specific facilities — those that are doctor-owned, for instance — are sparking criticism.

1 Mar 2011

Study confirms risk of triple-negative breast cancer among obese, physically inactive women

New findings published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, confirm the risk of breast cancer among women who are obese and not physically active, and suggests additional mechanisms beyond estrogen.

1 Mar 2011

HIV women take photos to document their lives

A picture may be worth a thousand words, but for women living with human immunodeficiency virus, the virus that causes AIDS, a picture can help them deal with the challenges of living with the virus.

1 Mar 2011

Regular exercise cuts risk of bowel cancer

People with an active lifestyle are up to three times less likely to develop large or advanced polyps in the bowel - which can develop into bowel cancer - according to a new analysis published in the British Journal of Cancer today (Wednesday).

1 Mar 2011

Leisure activities during free time can improve communication, social skills in autistic adults

Free time is not always a fun time for people with autism. Giving them the power to choose their own leisure activities during free time, however, can boost their enjoyment, as well as improve communication and social skills, according to an international team of researchers.

1 Mar 2011

LA Times: Blue Shield terms proposed hikes 'reasonable'

Blue Shield of California, assailed by consumers and state regulators for seeking to hike insurance rates as much as 59 percent in recent months, declared after a review that its proposed rates are reasonable (Helfand, 3/1).

1 Mar 2011

Bayhill's BHT-3034 receives FDA IND clearance for treatment of myasthenia gravis

Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.

1 Mar 2011

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccines.

1 Mar 2011

New CPR method improves long-term survival rates in patients with cardiac arrest by 50%

A five-year clinical trial led by University of Minnesota Medical School researchers has led to a new method of cardiopulmonary resuscitation that improves long-term survival rates with good brain function by 50 percent.

1 Mar 2011

Study: Happy people tend to live longer and experience better health

A review of more than 160 studies of human and animal subjects has found "clear and compelling evidence" that - all else being equal - happy people tend to live longer and experience better health than their unhappy peers.

1 Mar 2011

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.

1 Mar 2011

New study: Enzyme that metabolizes vitamin D can predict lung cancer survival

Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer survival.

1 Mar 2011

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

Bristol-Myers Squibb announced today that BARACLUDE(R) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B in adult patients with evidence of decompensated liver disease.

1 Mar 2011

FDA approves roflumilast to treat COPD

The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups or worsening of symptoms from severe chronic obstructive pulmonary disease.

1 Mar 2011

IRX Therapeutics signs research collaboration agreement with world's leading pharma companies

IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world's leading research-based pharmaceutical companies.

1 Mar 2011

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin in combination with chemotherapy for the treatment of newly diagnosed systemic anaplastic large cell lymphoma patients.

1 Mar 2011

Medical News

Nanotechnology holds promise for developing surgical measures

Nations meet to negotiate international food aid terms

New research finds link between genomic variants in neurological processes and autism

Researchers discover three genes that contribute to abnormal growth

Market demands shape health sector growth

Study confirms risk of triple-negative breast cancer among obese, physically inactive women

HIV women take photos to document their lives

Regular exercise cuts risk of bowel cancer

Leisure activities during free time can improve communication, social skills in autistic adults

LA Times: Blue Shield terms proposed hikes 'reasonable'

Bayhill's BHT-3034 receives FDA IND clearance for treatment of myasthenia gravis

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

New CPR method improves long-term survival rates in patients with cardiac arrest by 50%

Study: Happy people tend to live longer and experience better health

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

New study: Enzyme that metabolizes vitamin D can predict lung cancer survival

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

FDA approves roflumilast to treat COPD

IRX Therapeutics signs research collaboration agreement with world's leading pharma companies

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News